Ping Liang, PhD
Affiliations: | Stanford University, Palo Alto, CA |
Google:
"Ping Liang"Mean distance: 16.04 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentor| Jie Zheng | grad student | UC Davis | |
| Joseph C. Wu | post-doc | 2011-2014 | Stanford University Medical School (Physics Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sun Y, Su J, Wang X, et al. (2023) Patient-specific iPSC-derived cardiomyocytes reveal variable phenotypic severity of Brugada syndrome. Ebiomedicine. 95: 104741 |
| Pan Z, Liang P. (2023) Human-Induced Pluripotent Stem Cell-Based Differentiation of Cardiomyocyte Subtypes for Drug Discovery and Cell Therapy. Handbook of Experimental Pharmacology |
| Zhou J, Cui B, Wang X, et al. (2023) Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Research & Therapy. 14: 92 |
| Sun Y, Zhou J, Wang H, et al. (2022) Establishment of an induced pluripotent stem cell line (ZJULLi004-A) from a hypertrophic cardiomyopathy patient carrying MYBPC3/c.3764C>A mutation. Stem Cell Research. 64: 102898 |
| He X, Song S, Yang P, et al. (2022) A rare radiotherapy-sensitive primitive neuroectodermal tumor with gene amplification in an adult: a case report and literature review. The Journal of International Medical Research. 50: 3000605221118704 |
| Zhou J, Sun Y, Wang H, et al. (2022) Generation of an induced pluripotent stem cell line (ZJULLi003-A) from a hypertrophic cardiomyopathy patient carrying MYH7/c.4384G > A mutation. Stem Cell Research. 64: 102883 |
| Guo F, Sun Y, Wang H, et al. (2022) Generation of an induced pluripotent stem cell line from a long QT syndrome patient carrying KCNH2/1956C > A mutation. Stem Cell Research. 62: 102813 |
| Qiu H, Sun Y, Pan Z, et al. (2021) Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell-derived cardiomyocytes with a MYBPC3 mutation. Clinical and Translational Medicine. 11: e647 |
| Yu M, Lei W, Cao J, et al. (2021) Requirements for human cardiomyocytes. Cell Proliferation. e13150 |
| Wang X, Pan Z, Wang J, et al. (2021) Characterization of the molecular mechanisms underlying azithromycin-induced cardiotoxicity using human-induced pluripotent stem cell-derived cardiomyocytes. Clinical and Translational Medicine. 11: e549 |